Syngene International Ltd
SYNGENEBSE 539268Healthcare Research, Analytics & TechnologyMkt cap ₹14,570 Cr
Whole group, including subsidiaries — the figures companies headline.
Revenue · Q1 FY27
₹736 Cr
YoY -15.8%QoQ -29.0%
Net profit · Q1 FY27
₹-9.00 Cr
YoY -110.4%QoQ -106.1%
Net margin · Q1 FY27
-1.2%
-11.1 pts vs Q1 FY26
Net profit · FY26
₹317 Cr
YoY -36.2%
Quarterly results
| ₹ Cr | Q1 FY27 Apr–Jun 2026 | Q4 FY26 Jan–Mar 2026 | Q3 FY26 Oct–Dec 2025 | Q2 FY26 Jul–Sep 2025 | Q1 FY26 Apr–Jun 2025 | YoY |
|---|---|---|---|---|---|---|
| Revenue | 736 | 1,037 | 917 | 911 | 875 | -15.8% |
| Other income | 25.30 | 22.20 | 15.40 | 15.40 | 17.70 | +42.9% |
| Total income | 761 | 1,059 | 933 | 926 | 892 | -14.7% |
| Profit before tax | 0.00 | 196 | 28.40 | 85.20 | 101 | -100.0% |
| Tax | -10.20 | 48.10 | 13.40 | 18.10 | 14.60 | -169.9% |
| Net profit | -9.00 | 148 | 15.00 | 67.10 | 86.70 | -110.4% |
| Net margin | -1.2% | 14.3% | 1.6% | 7.4% | 9.9% |
Annual results
| ₹ Cr | FY26 Apr 2025–Mar 2026 | FY25 Apr 2024–Mar 2025 | FY24 Apr 2023–Mar 2024 | FY23 Apr 2022–Mar 2023 | FY22 Apr 2021–Mar 2022 | YoY |
|---|---|---|---|---|---|---|
| Revenue | 3,739 | 3,642 | 3,489 | 3,193 | 2,604 | +2.6% |
| Other income | 70.70 | 71.80 | 90.60 | 70.90 | 52.80 | -1.5% |
| Total income | 3,809 | 3,714 | 3,579 | 3,264 | 2,657 | +2.6% |
| Profit before tax | 411 | 660 | 621 | 594 | 484 | -37.7% |
| Tax | 94.20 | 164 | 111 | 129 | 88.60 | -42.5% |
| Net profit | 317 | 496 | 510 | 464 | 396 | -36.2% |
| Net margin | 8.5% | 13.6% | 14.6% | 14.5% | 15.2% |
BIC's take
We haven't covered Syngene International Ltd yet. Browse our sector reports →
Source: BSE filings · Data as of 2 Oct 2026, 6:37 pm IST· ₹ crore unless stated. Covers BSE 500 companies only. Consolidated figures include subsidiaries; standalone is the parent company alone. Growth is shown only against a positive base. Not investment advice — check the company's full filing before acting.